(4S,5S)-5-methyl-N-((S)-1-((R)-2-methylpyrrolidin-1-yl)-1-oxo-3-(thiazol-4-yl)propan-2-yl)-2-oxooxazolidine-4-carboxamide

Catalog No. :
ACDJQJ370
CAS No. :
204386-76-5
Molecular Formula :
C16H22N4O4S
Molecular Weight :
366.44

IUPAC Name:(4S,5S)-5-methyl-N-((S)-1-((R)-2-methylpyrrolidin-1-yl)-1-oxo-3-(thiazol-4-yl)propan-2-yl)-2-oxooxazolidine-4-carboxamide

(4S,5S)-5-methyl-N-((S)-1-((R)-2-methylpyrrolidin-1-yl)-1-oxo-3-(thiazol-4-yl)propan-2-yl)-2-oxooxazolidine-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4S,5S)-5-methyl-N-((S)-1-((R)-2-methylpyrrolidin-1-yl)-1-oxo-3-(thiazol-4-yl)propan-2-yl)-2-oxooxazolidine-4-carboxamide
IUPAC Name(4S,5S)-5-methyl-N-((S)-1-((R)-2-methylpyrrolidin-1-yl)-1-oxo-3-(thiazol-4-yl)propan-2-yl)-2-oxooxazolidine-4-carboxamide
Molecular FormulaC16H22N4O4S
Molecular Weight366.44
SMILESC[C@@H]1OC(=O)N[C@@H]1C(=O)N[C@@H](CC1=CSC=N1)C(=O)N1CCC[C@H]1C
InChI KeyWTXWDXWZGJGIHV-URBCHYCLSA-N
Synonym4-Oxazolidinecarboxamide, 5-methyl-N-[(1S)-2-[(2R)-2-methyl-1-pyrrolidinyl]-2-oxo-1-(4-thiazolylmethyl)ethyl]-2-oxo-, (4S,5S)-;Rovatirelin;S 0373;S0373;S-0373
CAS No.204386-76-5

Synthetic Route by SureRoute

1. ACDJQJ370 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDJQJ370 route product structure diagram
    ACDJQJ370204386-76-5
Inquiry

2. ACDJQJ370 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPRKW439 route compound structure diagram
    ACPRKW439135324-85-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDJQJ370 route product structure diagram
    ACDJQJ370204386-76-5
Inquiry

Comments (0)